Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsBusiness

Lupin's South African arm inks commercial pact with Creso Pharma

As per the agreement, Creso has given Pharma Dynamics sole distribution rights of its products across South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Angola, Mozambique and Uganda, Lupin said in a statement.

August 26, 2019 / 05:30 PM IST

Drug firm Lupin on August 26 said its South African arm Pharma Dynamics has signed a commercial agreement with Creso Pharma for hemp oil-based cannaQIX products.

As per the agreement, Creso has given Pharma Dynamics sole distribution rights of its products across South Africa, Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Angola, Mozambique and Uganda, Lupin said in a statement.

"We hope that this agreement will form the foundation of a longstanding relationship as we grow our footprint from nutraceuticals into the scheduled market as well," Pharma Dynamics CEO Erik Roos said.

Creso Pharma is globally recognised as a leader in the production of cannabis products with distribution agreements already in place in various countries in Europe and Asia-Pacific, he added.

"We are encouraged to see a wide range of opportunities opening up to bring premium hemp oil nutraceutical products to customers in South Africa," Creso Pharma CEO and co-founder Miri Halperin Wernli said.

Close

The cannaQIX range of products are cannabidiol hemp oil-based nutraceuticals that are used for reducing stress and to support mental and nervous functions.

Shares of Lupin Ltd closed at Rs 747.30 per scrip on the BSE, up 1.21 percent from its previous close.
PTI
first published: Aug 26, 2019 05:20 pm

stay updated

Get Daily News on your Browser
Sections